Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2008-003661-19-BE
EUCTR2008-003661-19-BE
Active, not recruiting
Phase 1

Invloed van laag gedoseerde hormonale substitutie op insulinespiegels bij postmenopausale vrouwen

niversity Hospital Ghent0 sitesMay 29, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsAngeliq

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Hospital Ghent
Status
Active, not recruiting
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 29, 2009
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
niversity Hospital Ghent

Eligibility Criteria

Inclusion Criteria

  • •\- Postmenopausaal
  • •\- Leeftijd van 65 jaar of ouder
  • •\- Nog geen HRT genomen in het verleden of HRT stop en 8 weken wash\-out
  • •\- Bereid tot nemen van lage dosis oestrogenen
  • •\- Mammografie, maximum 1 jaar geleden
  • •\- BMI \= 25 of BMI \> 25
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range

Exclusion Criteria

  • •\- Voorgeschiedenis van hormoongevoelige tumoren (bv. borstkanker, endometriumkanker,..)
  • •\- Contra\-indicaties voor hormonale substitutie therapie (bv. CVA, trombosen, …)
  • •\- Diabetes
  • •\- Afwijkend klinisch onderzoek bij aanvang van de studie (verdikt endometrium op echo, palpabele borstnodus, ovariële cyste op echo,…).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The Effect of Low Dose Hormone Replacement Therapy or Raloxifene on Bone and Lipid Metabolism in Hemodialysis PatientsPostmenopausal osteopenia in hemodialysis patients
JPRN-C000000390Department of Nephrology, Osaka University School of Medicine39
Active, not recruiting
Not Applicable
Den endokrine effekt af enten r-LH eller lav dosis r-hCG tilskud til r-FSH stimulering hos normogonadotrope kvinder som gennemgår IVF/ICSI behandling efter en lang GnRH agonist nedreguleringsprotocol - Et prospektivt randomiseret kontrolleret ikke blindet pilot studieFertilitetsbehandling.Sammenligne de endokrine effekter, specielt E2 niveau på hCG dagen hos normogonadatrope IVF/ICSI patienter, som får tilskud af LH aktivitet i form af enten rhCG eller rLHMedDRA version: 9.1Level: LLTClassification code 10016398Term: Female infertility
EUCTR2009-009375-35-DKRegionshospital skive
Active, not recruiting
Not Applicable
Modulation of response to hormonal therapy with lapatinib and/or metformin in patients with HER2-negative, ER and/or PgR positive metastatic breast cancer with progressive disease after first-line hormonal therapyFemale patients with HER2-negative, ER and/or PgR positive breast cancer in progression after first-line hormonal therapyMedDRA version: 14.1Level: SOCClassification code 10038604Term: Reproductive system and breast disordersSystem Organ Class: 10038604 - Reproductive system and breast disordersTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2011-000155-16-ITFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI
Completed
Phase 3
Comparative effects of 2 types of hormone replacement therapy on climacteric symptomsmenopause.Menopausal and female climacteric states
IRCT138809032766N1Tarbiat Maodares University150
Completed
Phase 2
Effect of hormonal therapy versus no treatment on testicular histopathology and fertility in patients with non-obstructive azoospermianon-obstructive azoospermia.Male infertility
IRCT201612069014N137Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences28